Private Advisor Group’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$385K Sell
83,353
-125,925
-60% -$624K ﹤0.01% 1959
2026
Q1
$969K Buy
209,278
+120,662
+136% +$629K ﹤0.01% 1439
2025
Q4
$443K Sell
88,616
-8,314
-9% -$43.3K ﹤0.01% 1903
2025
Q3
$491K Buy
96,930
+1,975
+2% +$8.7K ﹤0.01% 1788
2025
Q2
$409K Sell
94,955
-1,293
-1% -$6.39K ﹤0.01% 1791
2025
Q1
$580K Buy
96,248
+5,012
+5% +$25.3K ﹤0.01% 1525
2024
Q4
$360K Sell
91,236
-16,325
-15% -$73.1K ﹤0.01% 1762
2024
Q3
$629K Sell
107,561
-14,342
-12% -$70.7K ﹤0.01% 1488
2024
Q2
$525K Sell
121,903
-6,112
-5% -$29.3K ﹤0.01% 1536
2024
Q1
$602K Sell
128,015
-26,194
-17% -$100K ﹤0.01% 1406
2023
Q4
$757K Sell
154,209
-126,352
-45% -$619K 0.01% 1260
2023
Q3
$1.53M Buy
280,561
+32,337
+13% +$259K 0.01% 830
2023
Q2
$2.33M Buy
248,224
+16,455
+7% +$139K 0.02% 658
2023
Q1
$1.91M Sell
231,769
-17,486
-7% -$193K 0.02% 705
2022
Q4
$957K Buy
249,255
+13,125
+6% +$153K 0.05% 381
2022
Q3
$2.8M Buy
236,130
+8,808
+4% +$133K 0.03% 510
2022
Q2
$3.47M Buy
227,322
+92,585
+69% +$1.67M 0.03% 521
2022
Q1
$2.85M Buy
134,737
+14,920
+12% +$321K 0.02% 649
2021
Q4
$2.83M Buy
119,817
+2,906
+2% +$62.2K 0.02% 675
2021
Q3
$2.35M Buy
116,911
+2,724
+2% +$55.8K 0.01% 822
2021
Q2
$2.29M Buy
114,187
+9,505
+9% +$203K 0.02% 716
2021
Q1
$2.23M Buy
104,682
+2,963
+3% +$63.7K 0.02% 669
2020
Q4
$2.22M Sell
101,719
-7,952
-7% -$155K 0.02% 628
2020
Q3
$1.93M Sell
109,671
-3,053
-3% -$56.8K 0.03% 570
2020
Q2
$2.12M Sell
112,724
-521
-0.5% -$9.23K 0.03% 517
2020
Q1
$1.96M Buy
113,245
+6,265
+6% +$131K 0.04% 447
2019
Q4
$2.26M Buy
106,980
+8,863
+9% +$179K 0.04% 490
2019
Q3
$1.92M Buy
98,117
+351
+0.4% +$6.45K 0.03% 561
2019
Q2
$1.71M Buy
97,766
+2,080
+2% +$37.5K 0.03% 532
2019
Q1
$1.77M Buy
95,686
+26,670
+39% +$475K 0.03% 483
2018
Q4
$1.11M Sell
69,016
-25,512
-27% -$404K 0.03% 549
2018
Q3
$1.41M Buy
94,528
+33,800
+56% +$493K 0.03% 537
2018
Q2
$849K Buy
60,728
+12,725
+27% +$169K 0.01% 534
2018
Q1
$624K Buy
48,003
+17,079
+55% +$219K 0.02% 579
2017
Q4
$411K Sell
30,924
-30,267
-49% -$409K 0.02% 753
2017
Q3
$802K Sell
61,191
-256
-0.4% -$3.3K 0.02% 656
2017
Q2
$756K Buy
61,447
+1,153
+2% +$15.4K 0.02% 647
2017
Q1
$805K Buy
60,294
+1,841
+3% +$23.5K 0.02% 610
2016
Q4
$726K Sell
58,453
-2,356
-4% -$30.5K 0.02% 600
2016
Q3
$880K Sell
60,809
-11,011
-15% -$167K 0.04% 468
2016
Q2
$1.08M Buy
71,820
+2,811
+4% +$39.8K 0.04% 393
2016
Q1
$896K Buy
69,009
+2,648
+4% +$30.2K 0.04% 401
2015
Q4
$764K Sell
66,361
-12,460
-16% -$142K 0.04% 457
2015
Q3
$872K Sell
78,821
-5,932
-7% -$73.6K 0.05% 395
2015
Q2
$1.11M Buy
84,753
+4,638
+6% +$64.7K 0.05% 355
2015
Q1
$1.18M Sell
80,115
-10,072
-11% -$150K 0.07% 311
2014
Q4
$1.24M Buy
90,187
+70,418
+356% +$943K 0.08% 295
2014
Q3
$242K Buy
19,769
+3,387
+21% +$45K 0.02% 773
2014
Q2
$217K Buy
+16,382
New +$218K 0.02% 767

Other funds holding MPT

Private Advisor Group's MPT Position: Q2 2026 in Review

Private Advisor Group reduced its Medical Properties Trust (MPT) stake by 60% in Q2 2026, selling an estimated $624K and leaving 83,353 shares worth $385K. The position accounts for ﹤0.01% of the portfolio, ranked #1959.

Private Advisor Group first reported a position in MPT in Q2 2014 and has held it in 49 quarters since. The position peaked at $3.47M in Q2 2022. 161 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Private Advisor Group held 83,353 shares of Medical Properties Trust worth $385K as of Q2 2026.
  • Private Advisor Group sold 125,925 Medical Properties Trust shares in Q2 2026, an estimated $624K.
  • Medical Properties Trust made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1959 holding.
  • Private Advisor Group first reported a position in Medical Properties Trust in Q2 2014 and has held it in 49 quarters since.
  • Private Advisor Group's Medical Properties Trust position peaked at $3.47M in Q2 2022.
  • 161 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.